Evidence map›Paper›PMID 33827659›Full record

ArticleTrials2021

Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional.

Suzanne Phelan, Elissa Jelalian, Donald Coustan, Aaron B Caughey, Kristin Castorino, Todd Hagobian, Karen Muñoz-Christian, Andrew Schaffner, Laurence Shields, Casey Heaney and 2 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02763150 (Gestational Diabetes Prevention Program), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02763150 nacompletednot on this map

Gestational Diabetes Prevention Program

TypeinterventionalSponsorCalifornia Polytechnic State University-San Luis ObispoRan2017 to 2022Enrolled199ConditionsGestational Diabetes MellitusArmsLifestyle intervention, Health Promotion
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Suzanne PhelanDepartment of Kinesiology & Public Health, Center for Health Research, California Polytechnic State University, San Luis Obispo, CA, USA. sphelan@calpoly.edu.ORCID http://orcid.org/0000-0003-2260-0499
Elissa JelalianDepartment of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
Donald CoustanDepartment of Obstetrics and Gynecology, Alpert Medical School of Brown University, Providence, RI, USA.
Aaron B CaugheyDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
Kristin CastorinoSansum Diabetes Research Institute, Santa Barbara, CA, USA.
Todd HagobianDepartment of Kinesiology & Public Health, Center for Health Research, California Polytechnic State University, San Luis Obispo, CA, USA.
Karen Muñoz-ChristianDepartment of World Languages and Cultures, California Polytechnic State University, San Luis Obispo, CA, USA.
Andrew SchaffnerStatistics Department, California Polytechnic State University, San Luis Obispo, CA, USA.
Laurence ShieldsDignity Health, Marian Regional Medical Center, Santa Maria, CA, USA.
Casey HeaneyDepartment of Kinesiology & Public Health, Center for Health Research, California Polytechnic State University, San Luis Obispo, CA, USA.
Angelica McHughWeight Control and Diabetes Research Center, The Miriam Hospital, Providence, USA.
Rena R WingWeight Control and Diabetes Research Center, The Miriam Hospital, Providence, USA.
California Polytechnic State University · USBrown University · USDignity Health · USMiriam Hospital · USOregon Health & Science University · USSansum Diabetes Research Institute · US

Funding

Prevention of gestational diabetes through lifestyle modification before pregnancyR01HD084282 · NICHD · CALIFORNIA POLY STATE U SAN LUIS OBISPO · PI PHELAN, SUZANNE · 2016 to 2020
$2.8M
NICHD NIH HHS R01 HD084282
6 · The paper itself

Abstract

backgroundGestational diabetes mellitus (GDM) is associated with several maternal complications in pregnancy, including preeclampsia, preterm labor, need for induction of labor, and cesarean delivery as well as increased long-term risks of type 2 diabetes, metabolic syndrome, and cardiovascular disease. Intrauterine exposure to GDM raises the risk for complications in offspring as well, including stillbirth, macrosomia, and birth trauma, and long-term risk of metabolic disease. One of the strongest risk factors for GDM is the occurrence of GDM in a prior pregnancy. Preliminary data from epidemiologic and bariatric surgery studies suggest that reducing body weight before pregnancy can prevent the development of GDM, but no adequately powered trial has tested the effects of a maternal lifestyle intervention before pregnancy to reduce body weight and prevent GDM recurrence.

methodsThe principal aim of the Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional is to determine whether a lifestyle intervention to reduce body weight before pregnancy can reduce GDM recurrence. This two-site trial targets recruitment of 252 women with overweight and obesity who have previous histories of GDM and who plan to have another pregnancy in the next 1-3 years. Women are randomized within site to a comprehensive pre-pregnancy lifestyle intervention to promote weight loss with ongoing treatment until conception or an educational control group. Participants are assessed preconceptionally (at study entry, after 4 months, and at brief quarterly visits until conception), during pregnancy (at 26 weeks' gestation), and at 6 weeks postpartum. The primary outcome is GDM recurrence, and secondary outcomes include fasting glucose, biomarkers of cardiometabolic disease, prenatal and perinatal complications, and changes over time in weight, diet, physical activity, and psychosocial measures. DISCUSSION: The Gestational Diabetes Prevention /Prevención de la Diabetes Gestacional is the first randomized controlled trial to evaluate the effects of a lifestyle intervention delivered before pregnancy to prevent GDM recurrence. If found effective, the proposed lifestyle intervention could lay the groundwork for shifting current treatment practices towards the interconception period and provide evidence-based preconception counseling to optimize reproductive outcomes and prevent GDM and associated health risks.

trial registrationClinicalTrials.gov NCT02763150 . Registered on May 5, 2016.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2Pregnancy ComplicationsCesarean SectionFemaleHumansInfant, NewbornLife StylePregnancyRandomized Controlled Trials as TopicGestational diabetesLifestyle interventionPreconception weight lossRandomized controlled trial

Identifiers

PMID33827659
PMCPMC8024941
OpenAlexW3137597735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.